Oral Ozempic Delivers Mixed Results on Alcohol Use Semaglutide in pill form shows promise for alcohol use disorder STUDY: Schacht JP et al, American Journal of Psychiatry 2026 STUDY TYPE: Randomized, double-blind, placebo-controlled trial FUNDING: National Institute on Alcohol Abuse and Alcoholism, National Center for Advancing Translational Sciences, Hewit Family Foundation, anonymous donor Background GLP-1 drugs like semaglutide (Ozempic) have a mix of positive and negative data in alcohol use disorder, but most of the research has involved non-treatment seeking populations, which often differ in their responses
If delaying treatment poses a greater health risk, a clinician may initiate a GLP-1 while continuing to work on thyroid stabilization in parallel
An Intestinal Propulsion Promoting Substance from Perilla frutescens and Its Mechanism of Action
It also helps reduce the pleasurable response to food
This axis synergizes with LPS from gut microbiota translocation, elevating pro-inflammatory cytokine levels and amplifying inflammation (Tani et al., 2008)